BOTULINUM TOXIN A AS AN COADJUVANT IN THE TREATMENT OF CHRONIC HEADACHE: A Review
DOI:
https://doi.org/10.61164/rmnm.v13i1.1942Keywords:
Botulinum toxin, Migraine, headache disordersAbstract
Migraine is one of the most well-known headaches in the world. Despite not having a specific test, the diagnosis can be made quickly during a medical consultation, with accurate information provided by the patient. Over the years, botulinum toxin has been used mainly for aesthetic treatments, but research shows its effectiveness when used as an ally in the treatment of migraines. The objective of this work is to synthesize in a literature review the existing information related to the treatment of migraine using Botulinum Toxin A (TB-A). Literature review (2018 to 2021) using databases Medline, PubMed, SciELO, ScienceDirect and Portland Press, with the descriptors “botulinum toxin A, headache disorders, migraine” in Portuguese and English. It is concluded that the use of botulinum toxin A in the treatment of migraine affects the frequency and intensity of pain, being considered the safest and most effective current treatment when compared to the other therapeutic methods mentioned in the present study.
Downloads
References
RAJ KUMAR; Therapeutic use of botulinum toxin in pain treatment. Neuronal Signaling, 28 set. 2018. Disponível em: https:/doi.org/10.1042/NS20180058 Acesso em: 15 out. 2023. DOI: https://doi.org/10.1042/NS20180058
Biblioteca Virtual de Saúde, Enxaqueca. 2014. Fonte: Sociedade Brasileira de Cefaleia. Disponível em: https://bvsms.saude.gov.br/enxaqueca/. Acesso em: 08 abr. 2023.
MATAK et al. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins, Croácia, v. 11, n. 8, p. 459-482, 5 ago. 2019. Disponível em: https://doi.org/10.3390/toxins11080459. Acesso em: 16 out. 2023. DOI: https://doi.org/10.3390/toxins11080459
RYU, Jae Hyung et al. Ultrasound-guided greater occipital nerve block with chronic headache in the occipital area: a randomized controlled trial. Korean Journal Of Anesthesiology. Korea, p. 479-485. out. 2019. Disponível em: https://doi.org/10.4097/kja.19145. Acesso em: 10 abr. 2023. DOI: https://doi.org/10.4097/kja.19145
ZIROVICH, Milena D. et al. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: a randomized, placebo-controlled, cross-over study. Military Medicine. United States, p. 493-499. maio 2021. Disponível em: https://doi.org/10.1093/milmed/usaa391. Acesso em: 20 abr. 2023. DOI: https://doi.org/10.1093/milmed/usaa391
KIM, Hyeyun et al. Botulinum Toxin Type-A (Botulax®) Treatment in Patients with Intractable Chronic Occipital Neuralgia: a pilot study. Toxins, Korea, v. 13, n. 5, p. 332-337, 4 maio 2021. Disponível em: https://doi.org/10.3390/toxins13050332. Acesso em: 15 out. 2023. DOI: https://doi.org/10.3390/toxins13050332
SANZ, A. Castrillo et al. Experiencia con toxina botulínica en la migraña crónica. Neurología, Segovia, v. 33, n. 8, p. 499-504, out. 2018. Disponível em: https://doi.org/10.1016/j.nrl.2016.09.004. Acesso em: 16 out. 2023. DOI: https://doi.org/10.1016/j.nrl.2016.09.004
STARK, Catherine et al. Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study. The Journal Of Headache And Pain, Australia, v. 20, n. 1, p. 1-10, 15 jul. 2019. Disponível em: https://doi.org/10.1186/s10194-019-1030-z. Acesso em: 16 out. 2023. DOI: https://doi.org/10.1186/s10194-019-1030-z
Mendes, K. D. S., Silveira, R. C. C. P., & Galvão, C. M. (2008). Integrative literature review: a research method to incorporate evidence in health care and nursing. Texto & Contexto - Enfermagem, 17(4), 758-764. DOI: https://doi.org/10.1590/S0104-07072008000400018
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
